Pacira BioSciences (PCRX) Change in Receivables (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Change in Receivables of $1.6 million for Q1 2026, up 118.31% year-over-year from $717792.5 in Q1 2025, and down 82.19% quarter-over-quarter from $8.8 million in Q4 2025.
Pacira BioSciences (PCRX) Change in Receivables (2010 - 2026) Analysis & Trends
Pacira BioSciences' Change in Receivables history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 118.31% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $20.9 million (up 571.86% YoY), while the FY2025 annual figure was $10.7 million, up 38.64% from the prior year.
- Change in Receivables for Q1 2026 stood at $1.6 million, down from $8.8 million in the prior quarter.
- The five-year high for Change in Receivables was $12.7 million in Q4 2024, with the low at -$8.6 million in Q1 2025.
- The 5-year median for Change in Receivables is $1.6 million (2026), against an average of $1.7 million.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables slumped 812.34% in 2022, then surged 688.68% in 2023.
- Pacira BioSciences' Change in Receivables stood at $4.9 million in 2022, then soared by 74.56% to $8.6 million in 2023, then surged by 47.12% to $12.7 million in 2024, then plunged by 30.45% to $8.8 million in 2025, then sank by 82.19% to $1.6 million in 2026.
- Business Quant data shows PCRX's Change in Receivables at $1.6 million in Q1 2026, $8.8 million in Q4 2025, and $897000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 10.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.51 Mn |
| Jun 30, 2026 | 10.51 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | 8.80 Mn |
| Dec 31, 2025 | 8.80 Mn |
| Sep 30, 2025 | 897,000.00 |
| Sep 30, 2025 | 897,000.00 |
| Jun 30, 2025 | 9.61 Mn |
| Jun 30, 2025 | 9.61 Mn |
| Mar 31, 2025 | -8.56 Mn |
| Mar 31, 2025 | -8.56 Mn |
| Dec 31, 2024 | 12.65 Mn |
| Dec 31, 2024 | 12.65 Mn |
| Sep 30, 2024 | -4.13 Mn |
| Sep 30, 2024 | -4.13 Mn |
| Jun 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 3.14 Mn |
| Mar 31, 2024 | -3.92 Mn |
| Mar 31, 2024 | -3.92 Mn |